Construction of an in vitro evaluation system for novel aldosterone production inhibitors using cells derived from aldosterone producing adenomas (Sample provision to Pharmaceutical Research Department, NISSAN CHEMICAL CO., LTD.)

Not Applicable

• Conditions: Aldosterone producing adenoma

• Registration Number: JPRN-UMIN000033401
• Lead Sponsor: Saitama Medical University International Medical Center

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-08-03
• Study Completion: 2020-07-23
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Not provided

Exclusion Criteria

Patients who did not obtain consent

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Discovered adrenal tissue is dispersed in a single cell and aldosterone producing cells are extracted. The extracted cells are seeded on a plate, cultured for a certain period of time, the culture supernatant is collected, and the concentration of steroid containing aldosterone is measured to confirm that they are aldosterone producing cells.

Secondary Outcome Measures

Name	Time	Method
ot applicable